Ophthalmic Devices: Technologies and Global Markets

Report Highlights

The global market for ophthalmic devices is estimated to increase from $47.5 billion in 2022 to reach $64.2 billion by 2027, at a compound annual growth rate (CAGR) of 6.2% from 2022 through 2027.

Report Includes

• 50 data tables and 13 additional tables
• A detailed overview and up-to-date analysis of the global markets for ophthalmic devices and related technologies
• Analyses of the global and regional market trends, with data for 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
• Discussion of the industry growth driving factors and challenges that will shape the market for ophthalmic devices as a basis for projecting demand over the next few years (2022-2027)
• Estimation of the actual market size and revenue forecast for global ophthalmic devices market in USD millions, and corresponding market share analysis by technology type, application, and region
• Analysis of the recent advances in contact lenses, cataract surgery, implantation ophthalmic devices, and complex medical surgeries; and their potential impact on diagnosis of prevalent eye conditions and improved healthcare solutions
• In-depth information (facts and figures) concerning major market dynamics, technology updates, latest developments, industry regulations, and other macroeconomic forces affecting the present and future market outlook
• Assessment of the recent industry structure, ongoing research activities, analysis of competitive environment, and COVID-19 effects on the ophthalmic devices market ecosystem
• Patent review and analysis of patent grants on ophthalmic device technologies
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Descriptive company profiles of the market leading players, including EssilorLuxottica, Alcon, Bausch & Lomb, Carl Zeiss Meditec, CooperVision, Johnson & Johnson, Nidek, Topcon Corp., and Hoya Vision Care

Report Scope

During the last few years, significant improvements have been made in diagnosing ophthalmic conditions such as glaucoma, macular degeneration, and other retinal disorders. The market has been fueled by favorable reimbursement of ocular devices and surgery in the U.S. and more excellent healthcare insurance coverage in Europe. Advancements in cataract and refractory surgery devices have improved the safety and efficacy of routine procedures, enhanced surgical outcomes, and reduced perioperative morbidity.

The current report provides detailed information about the ophthalmic devices-global market. This report highlights this medical equipment’s current and future market potential and a detailed analysis of the market’s drivers, challenges, and opportunities. Revenues are broken down by region, type, and application. For market estimates, data has been provided for 2019, 2020, and 2021 (as the base year), 2022, and a forecast for 2027. The report also covers market share for major market players. It includes the company profiles of the major players with detailed information about their business segments, financials, product portfolios, recent developments, and pipeline products. It also provides the impact of the COVID-19 pandemic on this market.

This report on ophthalmic devices provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world. Finally, it will provide insights regarding new developments in ophthalmic and surgical devices that help to improve diagnosis and enhance the treatment of cataracts, glaucoma, and refractory and retinal disorders.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.